comparemela.com

Latest Breaking News On - Irritable bowel syndrome ibs - Page 1 : comparemela.com

Bloating in IBS-C: Can Plecanatide Help Patients?

Patients with IBS-C and moderate to severe bloating achieved reductions in bloating after receiving plecanatide, but those with mild bloating showed no improvement.

United statesAnn arborDarrenm brennerPrashant singhDrug administrationNorthwestern university feinberg school of medicineDepartment of medicineDivision of gastroenterologyUniversity of michiganNorthwestern university feinberg schoolDigestive diseasesIrritable bowel syndrome ibsBloating abdominalPain managementAbdominal painDiarrhea diarrhoea

Psychological Approaches Calm Functional Digestive Disorders

Hypnosis, mindfulness meditation, and cognitive-behavioral therapy have shown particular benefits in irritable bowel syndrome.

France generalUnited kingdomPauline jouAssociation of patientsFrancophone daysDigestive oncologyLouis mourier hospitalIrritable bowel syndromeSeverity scoreMindfulness based stress reductionIrritable bowel syndrome ibsComplementary and alternative medicine treatmentLternate medical therapy alternate medicineCognitive behavior therapyCognitive behavioral therapyAnxiety disorder

Which Probiotics Are Effective in Irritable Bowel Syndrome?

A gastroenterologist reviewed the data about probiotics at the Francophone Days of Hepatology, Gastroenterology, and Digestive Oncology.

France generalJean marc sabatAmerican college of gastroenterologyUniversity college corkWorld gastroenterology organizationMarc sabatAvicenne hospitalFrancophone daysAmerican collegeSymptom severity scoreIrritable bowel syndrome ibsComplementary and alternative medicine treatmentLternate medical therapy alternate medicineAbdominal painPain managementBloating abdominal

Ultraprocessed Food May Increase Long-Term Risk for IBS

Higher consumption of ultraprocessed food is tied to long-term risk of developing irritable bowel syndrome.

Shanshan wuCapital medical universityNational clinical research centerUnited kingdom biobankBeijing friendship hospitalDigestive diseaseClinical gastroenterologyIrritable bowel syndrome ibsAlignant neoplasiaAlignant neoplasmClinical researchClinical trialsLinical studiesPre clinical trialDouble blind studyDouble blind studies

Tenapanor Shows Response in IBS-C Within Weeks

A post hoc analysis of three clinical trials shows the drug works within weeks to improve bowel function and abdominal symptoms in people with IBS-C.

Cleveland clinicUnited statesBritish columbiaBrian lacyAnthony lemboAmerican college of gastroenterologyDrug administrationCleveland clinic digestive disease surgery instituteMayo clinicAmerican collegeDigestive diseaseSurgery instituteTexas health science centerIrritable bowel syndrome ibsAbdominal painBloating abdominal

vimarsana © 2020. All Rights Reserved.